BCR and Bruton-type agammaglobulinemia: The phenotype of X-linked agammaglobulinemia (XLA) patients and the finding that BTK inhibition blocks downstream signaling underscores BTK’s central role in the BCR signaling pathway (Honigberg et al., 2010).